Covax, which aimed to help low- and middle-income countries, is now aiming to have delivered 800 million doses by the end of 2021, but officials say even that lower target is not guaranteed. A slow pace of supply from manufacturers, vaccine hoarding by wealthy nations and logistical problems in recipient countries have all lowered its ambitions. |
No comments:
Post a Comment